Cancer Research Cancer Genome no Abstract  Cancer Genome no Abstract
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erdman, S. E.
Right arrow Articles by Fox, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erdman, S. E.
Right arrow Articles by Fox, J. G.
[Cancer Research 63, 6042-6050, September 15, 2003]
© 2003 American Association for Cancer Research


Immunology

CD4+CD25+ Regulatory Lymphocytes Require Interleukin 10 to Interrupt Colon Carcinogenesis in Mice1

Susan E. Erdman2, Varada P. Rao, Theofilos Poutahidis3, Melanie M. Ihrig, Zhongming Ge, Yan Feng, Michal Tomczak, Arlin B. Rogers, Bruce H. Horwitz and James G. Fox

Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 [S. E. E., V. P. R., T. P., M. M. I., Z. G., Y. F., A. B. R., J. G. F.]; Immunology Research Division, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts 02115 [M. T., B. H. H.]; and Division of Emergency Medicine, Children’s Hospital, Boston, Massachusetts 02115 [B. H. H.]

Roles for host immune response in carcinogenesis are not well defined. Recent studies have shown that microbially driven inflammation can lead to colon cancer and that prior transfer of regulatory lymphocytes expressing CD4 and CD25 prevents the innate inflammatory events that lead to colon cancer in mice. To further examine the ability of regulatory lymphocytes to inhibit carcinogenesis, 129/SvEv Rag-2-deficient mice were inoculated by gastric gavage with Helicobacter hepaticus, an enteric bacterial pathogen of mice. Mice were then treated at 1, 3, or 12 months after infection with adoptive transfer of CD4+CD45RBloCD25+-regulatory cells. Mice dosed with regulatory cells at 4 or 12 weeks after H. hepaticus infection had reduced severity of inflammatory bowel disease and significantly lower risk of colon cancer during the 8 month observation period, compared with infected mice that had not received cells. This suggested that regulatory cells were able to interrupt the ongoing innate immune events in the stepwise progression to cancer. Transfer of regulatory cells into chronically infected mice with established cancer reduced severity of colitis, epithelial dysplasia, and cancer, but did not eliminate all tumors. Regulatory cells lacking anti-inflammatory cytokine interleukin (IL)-10 were unable to inhibit inflammatory bowel disease, dysplasia, or cancer, showing that IL-10 was required for the protective effects of lymphocytes in this setting. Taken together, the data suggest that IL-10-mediated suppression of host innate inflammatory response was pivotal in interrupting carcinogenesis. Regulatory lymphocytes and cytokines may have implications for novel therapies for colon cancer in humans.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
L. Maggio-Price, P. Treuting, H. Bielefeldt-Ohmann, A. Seamons, R. Drivdahl, W. Zeng, L. Lai, M. Huycke, S. Phelps, T. Brabb, et al.
Bacterial Infection of Smad3/Rag2 Double-Null Mice with Transforming Growth Factor-{beta} Dysregulation as a Model for Studying Inflammation-Associated Colon Cancer
Am. J. Pathol., January 1, 2009; 174(1): 317 - 329.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Watanabe, V. P. Rao, T. Poutahidis, B. H. Rickman, M. Ohtani, S. Xu, A. B. Rogers, Z. Ge, B. H. Horwitz, T. Fujioka, et al.
Cytotoxic-T-Lymphocyte-Associated Antigen 4 Blockade Abrogates Protection by Regulatory T Cells in a Mouse Model of Microbially Induced Innate Immune-Driven Colitis
Infect. Immun., December 1, 2008; 76(12): 5834 - 5842.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Garcia, M. M. Ihrig, R. C. Fry, Y. Feng, S. Xu, S. R. Boutin, A. B. Rogers, S. Muthupalani, L. D. Samson, and J. G. Fox
Genetic Susceptibility to Chronic Hepatitis Is Inherited Codominantly in Helicobacter hepaticus-Infected AB6F1 and B6AF1 Hybrid Male Mice, and Progression to Hepatocellular Carcinoma Is Linked to Hepatic Expression of Lipogenic Genes and Immune Function-Associated Networks
Infect. Immun., May 1, 2008; 76(5): 1866 - 1876.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
J. G Fox
Helicobacter-Associated Chronic Inflammation and Gastrointestinal Cancer
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 375 - 380.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Poutahidis, K. M. Haigis, V. P. Rao, P. R. Nambiar, C. L. Taylor, Z. Ge, K. Watanabe, A. Davidson, B. H. Horwitz, J. G. Fox, et al.
Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma
Carcinogenesis, December 1, 2007; 28(12): 2614 - 2623.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C.-W. Lee, V. P. Rao, A. B. Rogers, Z. Ge, S. E. Erdman, M. T. Whary, and J. G. Fox
Wild-Type and Interleukin-10-Deficient Regulatory T Cells Reduce Effector T-Cell-Mediated Gastroduodenitis in Rag2-/- Mice, but Only Wild-Type Regulatory T Cells Suppress Helicobacter pylori Gastritis
Infect. Immun., June 1, 2007; 75(6): 2699 - 2707.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. P. Rao, T. Poutahidis, J. G. Fox, and S. E. Erdman
Breast Cancer: Should Gastrointestinal Bacteria Be on Our Radar Screen?
Cancer Res., February 1, 2007; 67(3): 847 - 850.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. T. Whary, S. J. Danon, Y. Feng, Z. Ge, N. Sundina, V. Ng, N. S. Taylor, A. B. Rogers, and J. G. Fox
Rapid Onset of Ulcerative Typhlocolitis in B6.129P2-IL10tm1Cgn (IL-10-/-) Mice Infected with Helicobacter trogontum Is Associated with Decreased Colonization by Altered Schaedler's Flora
Infect. Immun., December 1, 2006; 74(12): 6615 - 6623.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. F. Tomczak, S. E. Erdman, A. Davidson, Y. Y. Wang, P. R. Nambiar, A. B. Rogers, B. Rickman, D. Luchetti, J. G. Fox, and B. H. Horwitz
Inhibition of Helicobacter hepaticus-Induced Colitis by IL-10 Requires the p50/p105 Subunit of NF-{kappa}B
J. Immunol., November 15, 2006; 177(10): 7332 - 7339.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. H. Uhlig, J. Coombes, C. Mottet, A. Izcue, C. Thompson, A. Fanger, A. Tannapfel, J. D. Fontenot, F. Ramsdell, and F. Powrie
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
J. Immunol., November 1, 2006; 177(9): 5852 - 5860.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. S. Pratt, K. L. Sachen, H. D. Wood, K. A. Eaton, and V. B. Young
Modulation of Host Immune Responses by the Cytolethal Distending Toxin of Helicobacter hepaticus.
Infect. Immun., August 1, 2006; 74(8): 4496 - 4504.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. P. Rao, T. Poutahidis, Z. Ge, P. R. Nambiar, C. Boussahmain, Y. Y. Wang, B. H. Horwitz, J. G. Fox, and S. E. Erdman
Innate Immune Inflammatory Response against Enteric Bacteria Helicobacter hepaticus Induces Mammary Adenocarcinoma in Mice.
Cancer Res., August 1, 2006; 66(15): 7395 - 7400.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Kaparakis, K. L. Laurie, O. Wijburg, J. Pedersen, M. Pearse, I. R. van Driel, P. A. Gleeson, and R. A. Strugnell
CD4+ CD25+ Regulatory T Cells Modulate the T-Cell and Antibody Responses in Helicobacter-Infected BALB/c Mice.
Infect. Immun., June 1, 2006; 74(6): 3519 - 3529.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Maggio-Price, P. Treuting, W. Zeng, M. Tsang, H. Bielefeldt-Ohmann, and B. M. Iritani
Helicobacter Infection Is Required for Inflammation and Colon Cancer in Smad3-Deficient Mice
Cancer Res., January 15, 2006; 66(2): 828 - 838.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. R. Boutin, Z. Shen, A. B. Rogers, Y. Feng, Z. Ge, S. Xu, T. Sterzenbach, C. Josenhans, D. B. Schauer, S. Suerbaum, et al.
Different Helicobacter hepaticus Strains with Variable Genomic Content Induce Various Degrees of Hepatitis
Infect. Immun., December 1, 2005; 73(12): 8449 - 8452.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mocellin, F. M. Marincola, and H. A. Young
Interleukin-10 and the immune response against cancer: a counterpoint
J. Leukoc. Biol., November 1, 2005; 78(5): 1043 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z. Ge, Y. Feng, M. T. Whary, P. R. Nambiar, S. Xu, V. Ng, N. S. Taylor, and J. G. Fox
Cytolethal Distending Toxin Is Essential for Helicobacter hepaticus Colonization in Outbred Swiss Webster Mice
Infect. Immun., June 1, 2005; 73(6): 3559 - 3567.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Maggio-Price, H. Bielefeldt-Ohmann, P. Treuting, B. M. Iritani, W. Zeng, A. Nicks, M. Tsang, D. Shows, P. Morrissey, and J. L. Viney
Dual Infection with Helicobacter bilis and Helicobacter hepaticus in P-Glycoprotein-Deficient mdr1a-/- Mice Results in Colitis that Progresses to Dysplasia
Am. J. Pathol., June 1, 2005; 166(6): 1793 - 1806.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. E. Erdman, J. J. Sohn, V. P. Rao, P. R. Nambiar, Z. Ge, J. G. Fox, and D. B. Schauer
CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in ApcMin/+ Mice
Cancer Res., May 15, 2005; 65(10): 3998 - 4004.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. A. Pena, A. B. Rogers, Z. Ge, V. Ng, S. Y. Li, J. G. Fox, and J. Versalovic
Probiotic Lactobacillus spp. Diminish Helicobacter hepaticus-Induced Inflammatory Bowel Disease in Interleukin-10-Deficient Mice
Infect. Immun., February 1, 2005; 73(2): 912 - 920.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Mandell, A. P. Moran, A. Cocchiarella, J. Houghton, N. Taylor, J. G. Fox, T. C. Wang, and E. A. Kurt-Jones
Intact Gram-Negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus Bacteria Activate Innate Immunity via Toll-Like Receptor 2 but Not Toll-Like Receptor 4
Infect. Immun., November 1, 2004; 72(11): 6446 - 6454.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
A. B. Rogers, S. R. Boutin, M. T. Whary, N. Sundina, Zhongming Ge, K. Cormier, and J. G. Fox
Progression of Chronic Hepatitis and Preneoplasia in Helicobacter hepaticus-Infected A/JCr Mice
Toxicol Pathol, October 1, 2004; 32(6): 668 - 677.
[Abstract] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. H. Itzkowitz and X. Yio
Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G7 - G17.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. M. Huycke and H. R. Gaskins
Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models
Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. B. Rogers and J. G. Fox
Inflammation and Cancer I. Rodent models of infectious gastrointestinal and liver cancer
Am J Physiol Gastrointest Liver Physiol, March 1, 2004; 286(3): G361 - G366.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.